The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents
Year: 2017
Type: article
Source: Blood
Institution: National and Kapodistrian University of Athens
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2768845394
